Global Infusion Pumps Market: Snapshot

Infusion pumps are mainly used in hospitals and other healthcare service providers to deliver fluids and medication in to patient’s body in controlled manner. These infusion pumps improves patient care with control on antibiotics, anesthetics, insulin, and others. Infusion systems are devices which are used for administrating the drugs and fluids like saline, dextrose, and plasma solutions. Growing demand for volume infusion are required for hydration therapy and parenteral nutrition is fuelling growth of the global infusion pumps market. However, high cost of implantable devices are hampering growth of the global infusion pumps market. Nevertheless, tapping the unmet need are expected to create lucrative opportunities for key players to collect higher revenue.

According to the report by TMR, the global infusion pumps market was valued at around US$ 7,036 mn in 2017 and is anticipated to expand with a CAGR of around 5.4% from 2018 to 2026 to attain value of US$ 10,000.0 mn by the end of 2026.

infusion-pumps-market.jpg

High incidences of diabetes to be Beneficial for Growth

On the basis of product, the global infusion pumps market is segmented into insulin pumps, PCA pumps, and enteral pumps. Of these, insulin pumps segment accounted for the leading share in the global infusion pumps market and is anticipated to continue over forecast period followed by PCA pumps. This growth is attributable to the increase in prevalence of diabetes and development of advanced insulin pump.  

On the basis of end user, the global infusion pumps market is segmented into hospitals, ambulatory care settings, and home care settings. Of these, the hospitals segment accounted for a large share of the market in 2017 and is likely to continue its dominance during the forecast period. This growth is attributable to higher demand for infusion pumps from hospitals.

Based on the application, the global infusion pumps market is segmented into diabetes management, pain management, and chemotherapy. Of these, diabetes management segment dominated the global infusion pumps market in 2017 and is expected to remain dominant over the forecast period. This growth is attributable to growing prevalence of diabetes globally.

Growing Favorable Reimbursement Policies to Bolster Growth in Asia Pacific and Europe

On the basis of region, the global infusion pumps market is segmented into North America, Europe, Asia Pacific, Latin America, and Rest of the World. Of these, North America is dominating the global market for infusion pumps owing to large number of people using insulin for type-1 and type-2 diabetes patients. However, the markets in the Europe and Asia Pacific are expected to expand with expand with CAGR owing to growing awareness and initiatives from local governments in order to increase the awareness levels about benefits of the infusion pumps and improving production of infusive pumps market. Additionally, growing favorable reimbursement policies in the developing regions are creating growth opportunities in the global market.

Key players operating in the infusion pumps market include F. Hoffmann-La Roche Ltd., ICU MEDICAL, INC., Tandem Diabetes Care, Inc., Smiths Medical, and Medtronic plc. These prominent players are adopting strategies to improve their products and expand their business globally and to gain market shares.        

Global Infusion Pumps Market: Overview

Infusion pumps are used to deliver therapeutic drugs and fluids such as plasma, dextrose, and saline solutions into a patient’s body at a precise and controlled rate. These devices are utilized for infusion through several routes of administration such as intravenous, epidural, arterial, subcutaneous, peritoneal, enteral, and intrathecal. The global infusion pumps market is expanding at a significant pace due to factors such as increase in the number of patients with chronic pain, diabetes, and cancer worldwide.

The global infusion pumps market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product type, application, end-user, and region. A detailed qualitative analysis of drivers, restraints, and opportunities have been provided in the market overview section. Additionally, the section comprises competitive matrix and company profiles with business overview to understand competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global infusion pumps market.

Global Infusion Pumps Market: Key Segments

Based on product type, the global infusion pumps market can be segmented into insulin pumps, PCA pumps, enteral pumps, and others. The products in this segment have been analyzed based on different uses of infusion devices to treat chronic diseases in various region. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. In terms of application, the global infusion pumps market can be classified into diabetes management, pain management, chemotherapy, and others. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Infusion Pumps Market: Regional Outlook

In terms of geography, the global infusion pumps market has been categorized into five major regions and the key countries in the respective region: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, Israel, and Rest of MEA). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also provides the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the market and provides various attributes such as company overview, financial overview, product portfolios, business strategies, and recent developments. Major companies profiled in the infusion pumps market are include F. Hoffmann-La Roche Ltd., Tandem Diabetes Care, Inc., ICU MEDICAL, INC., Smith Medical, Medtronic plc, Terumo Corporation, Baxter International Inc., Becton, Dickinson and Company, B. Braun Holding GmbH & Co. KG, and Fresenius SE & Co. KGaA.

The global infusion pumps market has been segmented as follows:

Infusion Pumps Market, by Product (Value & Volume)

  • Insulin Pumps
  • PCA Pumps
  • Enteral Pumps
  • Others

Infusion Pumps Market, by Application

  • Diabetes Management
  • Pain Management
  • Chemotherapy
  • Others

Infusion Pumps Market, by End-user

  • Hospitals
  • Ambulatory Care Settings
  • Home Care Settings
  • Others

Infusion Pumps Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Rest of Middle East & Africa
.